JP2003508761A5 - - Google Patents

Download PDF

Info

Publication number
JP2003508761A5
JP2003508761A5 JP2001520897A JP2001520897A JP2003508761A5 JP 2003508761 A5 JP2003508761 A5 JP 2003508761A5 JP 2001520897 A JP2001520897 A JP 2001520897A JP 2001520897 A JP2001520897 A JP 2001520897A JP 2003508761 A5 JP2003508761 A5 JP 2003508761A5
Authority
JP
Japan
Prior art keywords
protein
molecule
encoding
encoded
linker
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001520897A
Other languages
English (en)
Japanese (ja)
Other versions
JP4803933B2 (ja
JP2003508761A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2000/023414 external-priority patent/WO2001016352A1/en
Publication of JP2003508761A publication Critical patent/JP2003508761A/ja
Publication of JP2003508761A5 publication Critical patent/JP2003508761A5/ja
Application granted granted Critical
Publication of JP4803933B2 publication Critical patent/JP4803933B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2001520897A 1999-08-27 2000-08-25 インビトロ翻訳タンパク質の符号化方法および選別方法 Expired - Lifetime JP4803933B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15126199P 1999-08-27 1999-08-27
US60/151,261 1999-08-27
PCT/US2000/023414 WO2001016352A1 (en) 1999-08-27 2000-08-25 Methods for encoding and sorting in vitro translated proteins

Publications (3)

Publication Number Publication Date
JP2003508761A JP2003508761A (ja) 2003-03-04
JP2003508761A5 true JP2003508761A5 (https=) 2010-06-24
JP4803933B2 JP4803933B2 (ja) 2011-10-26

Family

ID=22537976

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001520897A Expired - Lifetime JP4803933B2 (ja) 1999-08-27 2000-08-25 インビトロ翻訳タンパク質の符号化方法および選別方法

Country Status (6)

Country Link
US (2) US6436665B1 (https=)
EP (1) EP1212452B1 (https=)
JP (1) JP4803933B2 (https=)
AU (1) AU779653B2 (https=)
CA (1) CA2382545C (https=)
WO (1) WO2001016352A1 (https=)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2323638A1 (en) * 1998-04-03 1999-10-14 Phylos, Inc. Addressable protein arrays
DE19923966C2 (de) * 1999-05-25 2003-04-24 Phylos Inc Erkennungssystem zur Auftrennung von Probenbestandteilen, seine Herstellung und Verwendung
DK1196637T3 (da) * 1999-07-27 2007-07-30 Adnexus Therapeutics Inc Peptidacceptor-ligeringsmetoder
US6436665B1 (en) * 1999-08-27 2002-08-20 Phylos, Inc Methods for encoding and sorting in vitro translated proteins
DE19959857C1 (de) * 1999-12-10 2001-06-28 Aventis Res & Tech Gmbh & Co Testsystem zum Nachweis von Analyten sowie ein Verfahren zur Herstellung und Verwendung
EP1423400B2 (en) 2001-03-19 2013-05-22 President and Fellows of Harvard College Evolving new molecular function
US20030027194A1 (en) * 2001-07-31 2003-02-06 Markus Kurz Modular assembly of nucleic acid-protein fusion multimers
AU2002365404A1 (en) * 2001-11-27 2003-06-10 Compound Therapeutics, Inc. Solid-phase immobilization of proteins and peptides
WO2004016767A2 (en) 2002-08-19 2004-02-26 The President And Fellows Of Harvard College Evolving new molecular function
US20050069896A1 (en) * 2002-09-12 2005-03-31 Horvitz H. Robert Rb pathway and chromatin remodeling genes that antagonize let-60 Ras signaling
WO2005017109A2 (en) * 2003-06-30 2005-02-24 Massachusetts Institute Of Technology Nucleic acids and polypeptides required for cell survival in the absence of rb
WO2005074417A2 (en) * 2003-09-03 2005-08-18 Salk Institute For Biological Studies Multiple antigen detection assays and reagents
KR101337320B1 (ko) * 2003-11-20 2013-12-06 사노피 파스퇴르 인크 백일해 독소의 정제방법 및 이에 유용한 펩타이드
WO2005086679A2 (en) 2004-03-05 2005-09-22 Medical College Of Ohio Methods and compositions for assessing nucleic acids and alleles
WO2005106036A2 (en) 2004-04-12 2005-11-10 Medical College Of Ohio Methods and compositions for assaying analytes
US20050260652A1 (en) * 2004-04-15 2005-11-24 The General Hospital Corporation Compositions and methods that modulate RNA interference
US7635563B2 (en) * 2004-06-30 2009-12-22 Massachusetts Institute Of Technology High throughput methods relating to microRNA expression analysis
DK2339014T3 (en) 2005-11-16 2015-07-20 Ambrx Inc Methods and compositions comprising non-natural amino acids
US7749957B2 (en) 2006-04-06 2010-07-06 E.I. Du Pont De Nemours And Company Clay-binding peptides and methods of use
US7951559B2 (en) * 2007-07-25 2011-05-31 E.I. Du Pont De Nemours And Company Recombinant peptide production using a cross-linkable solubility tag
US7829311B2 (en) 2007-07-25 2010-11-09 E.I. Du Pont De Nemours And Company Ketosteroid isomerase inclusion body tag engineered to be acid-resistant by replacing aspartates with glutamate
US7678883B2 (en) * 2007-07-25 2010-03-16 E.I. Du Pont De Nemours And Company Solubility tags for the expression and purification of bioactive peptides
US7794963B2 (en) 2007-11-02 2010-09-14 E.I. Du Pont De Nemours And Company Use of tetracysteine tags in fluorescence-activated cell sorting analysis of prokaryotic cells producing peptides or proteins
US8420081B2 (en) 2007-11-30 2013-04-16 Abbvie, Inc. Antibody formulations and methods of making same
US8883146B2 (en) 2007-11-30 2014-11-11 Abbvie Inc. Protein formulations and methods of making same
ES2836128T3 (es) 2008-04-16 2021-06-24 Univ Johns Hopkins Método para determinar variantes del receptor de andrógenos en cáncer de próstata
EP2316030B1 (en) 2008-07-25 2019-08-21 Wagner, Richard W. Protein screeing methods
US20100158846A1 (en) * 2008-12-18 2010-06-24 E. I. Du Pont De Nemours And Company Hair-binding peptides
US8287845B2 (en) * 2008-12-18 2012-10-16 E I Du Pont De Nemours And Company Hair-binding peptides
US20100158837A1 (en) 2008-12-18 2010-06-24 E. I. Du Pont De Nemours And Company Iron oxide-binding peptides
US20100158822A1 (en) * 2008-12-18 2010-06-24 E .I. Du Pont De Nemours And Company Peptides that bind to silica-coated particles
ES2638324T3 (es) 2009-02-13 2017-10-19 X-Chem, Inc. Métodos de creación y examen de bibliotecas codificadas por ADN
JP2012522057A (ja) * 2009-03-30 2012-09-20 ジヨンソン・アンド・ジヨンソン・コンシユーマー・カンパニーズ・インコーポレーテツド 化粧用剤の送達のためのペプチドに基づく系
US8481678B2 (en) 2009-03-30 2013-07-09 E I Du Pont De Nemours And Company Peptide-based tooth whitening reagents
WO2010138709A1 (en) 2009-05-28 2010-12-02 Government Of The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Anti-tnf induced apoptosis (atia) diagnostic markers and therapies
US20120296403A1 (en) 2010-02-10 2012-11-22 Novartis Ag Methods and compounds for muscle growth
SG191153A1 (en) 2010-12-23 2013-07-31 Hoffmann La Roche Polypeptide-polynucleotide-complex and its use in targeted effector moiety delivery
DE102010056289A1 (de) 2010-12-24 2012-06-28 Geneart Ag Verfahren zur Herstellung von Leseraster-korrekten Fragment-Bibliotheken
GB2502238A (en) 2011-02-15 2013-11-20 Univ Johns Hopkins Compositions and methods for diagnosing ovarian cancer
ES2926988T3 (es) 2011-03-15 2022-10-31 X Body Inc Métodos de cribado de anticuerpos
CN103732738A (zh) 2011-04-28 2014-04-16 小利兰斯坦福大学托管委员会 与样品相关的多核苷酸的鉴定
IN2014CN02574A (https=) 2011-09-07 2015-06-26 Chem Inc X
AU2012347972B2 (en) 2011-12-05 2018-05-10 X-Body, Inc. PDGF receptor beta binding polypeptides
SG10201907347YA (en) 2012-07-13 2019-09-27 X Chem Inc Dna-encoded libraries having encoding oligonucleotide linkages not readable by polymerases
EP2948775B1 (en) 2013-01-23 2018-10-03 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Compositions and methods for detecting neoplasia
RU2015137617A (ru) 2013-03-14 2017-04-18 Юниверсити Оф Мэриленд, Балтимор Офис Оф Текнолоджи Трансфер Агенты, подавляющие андрогенные рецепторы, и их применение
US20140327460A1 (en) * 2013-05-03 2014-11-06 Second Sight Medical Products, Inc. Test Apparatus and Method for Determining Long Term Reliability of an Implantable Device
CA3210220A1 (en) 2013-05-10 2014-11-13 Johns Hopkins University Compositions for ovarian cancer assessment having improved specificity
MY191368A (en) 2013-06-28 2022-06-20 X Body Inc Target antigen discovery, phenotypic screens and use thereof for identification of target cell specific target epitopes
EP3779440A1 (en) 2013-09-23 2021-02-17 X-Body, Inc. Methods and compositions for generation of binding agents against cell surface antigens
WO2015179404A1 (en) 2014-05-19 2015-11-26 The Johns Hopkins University Methods for identifying androgen receptor splice variants in subjects having castration resistant prostate cancer
CA2959336A1 (en) 2014-08-25 2016-03-03 The Johns Hopkins University Methods and compositions related to prostate cancer therapeutics
JP6478392B2 (ja) * 2014-12-26 2019-03-06 国立研究開発法人産業技術総合研究所 核酸リンカー
US11998540B2 (en) 2015-12-11 2024-06-04 The General Hospital Corporation Compositions and methods for treating drug-tolerant glioblastoma
US12130290B2 (en) 2016-11-29 2024-10-29 Trustees Of Tufts College Compositions and methods for diagnosing breast cancer
EP3669004A1 (en) 2017-08-16 2020-06-24 Medimmune, LLC Compositions and methods for treatment of atopic dermatitis and treatment selection
US11988663B2 (en) 2018-12-18 2024-05-21 The University Of Memphis Research Foundation Compositions and methods for the detection and molecular profiling of membrane bound vesicles
WO2022197933A1 (en) 2021-03-18 2022-09-22 The Broad Institute, Inc. Compositions and methods for characterizing lymphoma and related conditions
WO2023122723A1 (en) 2021-12-23 2023-06-29 The Broad Institute, Inc. Panels and methods for diagnosing and treating lung cancer
WO2025106804A1 (en) 2023-11-16 2025-05-22 Massachusetts Institute Of Technology Compositions and methods for characterizing hepatocyte stress
WO2025217069A1 (en) 2024-04-08 2025-10-16 Beth Israel Deaconess Medical Center, Inc. Compositions and methods for treating cardiotoxicity

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639603A (en) * 1991-09-18 1997-06-17 Affymax Technologies N.V. Synthesizing and screening molecular diversity
JP2547149B2 (ja) * 1992-03-05 1996-10-23 三洋化成工業株式会社 免疫測定法及び免疫測定用試薬キット
GB2284208A (en) * 1993-11-25 1995-05-31 Pna Diagnostics As Nucleic acid analogues with a chelating functionality for metal ions
US5695934A (en) 1994-10-13 1997-12-09 Lynx Therapeutics, Inc. Massively parallel sequencing of sorted polynucleotides
ATE332368T1 (de) 1997-01-21 2006-07-15 Gen Hospital Corp Selektion von proteinen mittels rns-protein fusionen
US6261804B1 (en) 1997-01-21 2001-07-17 The General Hospital Corporation Selection of proteins using RNA-protein fusions
JPH10253632A (ja) * 1997-03-10 1998-09-25 Nissui Pharm Co Ltd 分析方法、キット及び装置
CA2323638A1 (en) * 1998-04-03 1999-10-14 Phylos, Inc. Addressable protein arrays
US6143503A (en) * 1998-04-17 2000-11-07 Whitehead Institute For Biomedical Research Use of a ribozyme to join nucleic acids and peptides
US5965352A (en) 1998-05-08 1999-10-12 Rosetta Inpharmatics, Inc. Methods for identifying pathways of drug action
JP4278872B2 (ja) * 1998-08-17 2009-06-17 フィロス インク． 蛋白質・核酸融合分子ライブラリーを用いた化合物・蛋白質相互作用の同定
US6436665B1 (en) * 1999-08-27 2002-08-20 Phylos, Inc Methods for encoding and sorting in vitro translated proteins

Similar Documents

Publication Publication Date Title
JP2003508761A5 (https=)
JP4803933B2 (ja) インビトロ翻訳タンパク質の符号化方法および選別方法
RU2238326C2 (ru) Способ продуцирования библиотеки белков (варианты), способ отбора нужного белка и нуклеиновой кислоты
US8207093B2 (en) Selection of proteins using RNA-protein fusions
CA2350417C (en) Dna-protein fusions and uses thereof
US6214553B1 (en) Libraries of protein encoding RNA-protein fusions
EP1816192B1 (en) LINKER FOR CONSTRUCTING mRNA-PUROMYCIN-PROTEIN CONJUGATE
EP3150750B1 (en) Peptide constructs and assay systems
US7125669B2 (en) Solid-phase immobilization of proteins and peptides
WO2009077173A2 (en) Dna-encoded chemical libraries
JPH04504409A (ja) 免疫親和技術を用いた連続ペプチド及びオリゴヌクレオチド合成
JPH10179197A (ja) 隣接してアニーリングしたプローブの三重らせん形成を用いる核酸の同定方法
JP2008253176A (ja) 高親和性分子取得のためのリンカー
JP5733784B2 (ja) ｃＤＮＡ／ｍＲＮＡ−タンパク質連結体の効率的合成法
WO2003062417A1 (fr) Produit de ligation arn-adn, et utilisation correspondante
US20040197779A1 (en) Methods for analyzing mixtures of proteins
JP2004097213A (ja) 核酸および／またはタンパク質の選択方法
JPWO2005001086A1 (ja) 固定化ｍＲＮＡ−ピューロマイシン連結体及びその用途
WO2021182587A1 (ja) 光架橋塩基を活用した、新規ペプチドアプタマー探索用標的モジュール、新規ペプチドアプタマー探索用リンカー及びそれらを用いる新規ペプチドアプタマーの探索方法
JP2003070483A (ja) 核酸の連結方法